Bank of America Spends 250 Million Dollars Per Year on Weight-Loss Drugs for Employees
BofA disclosed it now spends approximately 50 million annually on GLP-1 medications like Ozempic and Mounjaro for employees, highlighting the massive corporate burden of weight-loss drugs.